English Overview
From Clinical Trials to RWE in PsO, PsA and RA
This Activity for
- Resident / Fellow
- Physician
- Pharmacy
What I will learn?
•Present current scientific evidence, including clinical trials, Real-world data, and illustrative case studies, on the management of PsO, PsA and RA.
•Communicate Ixekizumab and Baricitinib value proposition to highlight what the product may mean to people living with Plaque Psoriasis (PsO), Psoriatic Arthritis (PsA) & Rheumatoid Arthritis (RA) respectively.
•Communicate Ixekizumab and Baricitinib value proposition to highlight what the product may mean to people living with Plaque Psoriasis (PsO), Psoriatic Arthritis (PsA) & Rheumatoid Arthritis (RA) respectively.
Additional items to the activity
| Optional Details | Type | Fee |
|---|---|---|
|
Transition from Clinical Trials to RWE in Plaque Psoriasis, Psoriatic Arthritis & Rheumatoid Arthritis Certificate
Certificate |
Certificate | Free |
VAT 15% Included
